Talk to the Institute
Published mark

Caris Life Sciences, Inc.

NASDAQ: CAI. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:8d0ee88f-5c33-4094-8769-1b6f153c3272
SEC CIK
0002019410
Website
www.carislifesciences.com Open
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
Newest evidence
May 11, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
David Dean HalbertChairman, Chief Executive Officer & Founder
Chair
Not published
Independent
8 / 1212 directors published
Published claims
413 distinct sources
Evidence records
190 pinned
Source conflicts
0None open

Built from 3 distinct sources and 19 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Brian J. Brille executive of Caris Life Sciences, Inc., effective 2026-04-23.

EffectiveEffective Apr 23, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Vice Chairman and Executive Vice PresidentBrian J. BrilleApr 2026currentSource reportedE4
Senior Vice President, General Counsel, and SecretaryJ. Russel DentonApr 2026currentSource reportedE9
Senior Vice President, Human ResourcesMichael HalbertApr 2026currentSource reportedE15
Senior VP, President of Japanese Operations & Head of InternationalAndreas S. TsukadaNot capturedunknownSource reportedE3
Chairman, Chief Executive Officer & FounderDavid Dean HalbertNot capturedunknownSource reportedE5
PresidentDavid SpetzlerNot capturedunknownSource reportedE6
Executive VP & Chief Medical OfficerGeorge W. Sledge Jr.Not capturedunknownSource reportedE7
Senior Vice President, Deputy General Counsel & Chief Compliance OfficerGinger AppleberryNot capturedunknownSource reportedE8
Senior Vice President of Human ResourcesJeremy O'BrienNot capturedunknownSource reportedE10
Senior VP & Chief Innovation OfficerJim AbrahamNot capturedunknownSource reportedE11
Senior Vice President & Chief Operations OfficerJon Mark HarmonNot capturedunknownSource reportedE12
Senior Vice President, Chief Financial Officer & Chief Accounting OfficerLuke PowerNot capturedunknownSource reportedE13
Senior VP, Chief Clinical Officer & Pathologist-in-ChiefMatthew OberleyNot capturedunknownSource reportedE14
Senior Vice President & Chief Scientific OfficerMilan RadovichNot capturedunknownSource reportedE16
Senior Vice President of Corporate DevelopmentNarendra ChokshiNot capturedunknownSource reportedE17
Senior Vice President & Chief Technology OfficerValeriy DomenyukNot capturedunknownSource reportedE18

Board of directors

Evidence

12 directors published. 8 of 12 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Brian J. BrilleNot independent2018None publishedSource reportedE2
Danny PhillipsIndependent2015None publishedSource reportedE2
David Dean HalbertNot independent2008None publishedSource reportedE2
David Dean Halbert, D.Sc. (h.c.)Not independent2008None publishedSource reportedE2
David FredricksonIndependent2024None publishedSource reportedE2
Dominic PhillipsIndependent2015Audit, chairAudit · ChairSource reportedE2
Jeffrey VacircaIndependent2024None publishedSource reportedE2
Jon S. HalbertNot independent2014None publishedSource reportedE2
Joseph E. GilliamIndependent2021AuditAudit; CompensationCompensationSource reportedE2
Laura I. JohansenIndependent2008CompensationSource reportedE2
Lloyd B. MinorIndependent2021None publishedSource reportedE2
Peter M. CastlemanIndependent2008AuditAudit; Compensation · ChairCompensation, chairSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditDominic PhillipsDominic Phillips, Joseph E. Gilliam, Peter M. CastlemanNot described in the published record
Audit · ChairNot publishedDominic PhillipsNot described in the published record
Audit; CompensationNot publishedJoseph E. GilliamNot described in the published record
Audit; Compensation · ChairNot publishedPeter M. CastlemanNot described in the published record
CompensationPeter M. CastlemanPeter M. Castleman, Joseph E. Gilliam, Laura I. JohansenNot described in the published record
Committee RecordAudit: Chair Dominic Phillips; Members Dominic Phillips (Chair); Joseph E. Gilliam; Peter M. Castleman
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_record:35
Committee AppointmentDominic Phillips: chair, Audit
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:36
Committee AppointmentJoseph E. Gilliam: member, Audit
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:37
Committee AppointmentPeter M. Castleman: member, Audit
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:38
Committee RecordCompensation: Chair Peter M. Castleman; Members Peter M. Castleman (Chair); Joseph E. Gilliam; Laura I. Johansen
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_record:39
Committee AppointmentPeter M. Castleman: chair, Compensation
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:40
Committee AppointmentJoseph E. Gilliam: member, Compensation
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:41
Committee AppointmentLaura I. Johansen: member, Compensation
Source reportedE19
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:committee_appointment:42

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerDavid Dean Halbert, Chairman, Chief Executive Officer & Founder
Source reportedE5
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:leadership_role:21
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingCAI (NASDAQ)
Source reportedE1
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:security_listing:43
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 17, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameCaris Life Sciences, Inc.
Source reportedE1
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:entity_status:3
Published FactIndustrials
Source reportedE1
company:8d0ee88f-5c33-4094-8769-1b6f153c3272:published_fact:6

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
19 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 5 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    CAI International DEF 14A 2026-04-23
    sec proxy. Published Apr 23, 2026. Retrieved May 11, 2026. Cited by 12 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    CAI DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 18, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    CAI DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 18, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  15. E15
    CAI DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 18, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  16. E16
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  17. E17
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  18. E18
    CAI International key executives
    other. Published May 11, 2026. Retrieved May 11, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  19. E19
    Audit
    board_seats. board seats. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026
  • Brian J. Brille executive of Caris Life Sciences, Inc., effective 2026-04-23.
  • J. Russel Denton executive of Caris Life Sciences, Inc., effective 2026-04-23.
  • Michael Halbert executive of Caris Life Sciences, Inc., effective 2026-04-23.
  • David Fredrickson seat on Caris Life Sciences, Inc., effective 2024-01-01.
  • Jeffrey Vacirca seat on Caris Life Sciences, Inc., effective 2024-01-01.
  • Joseph E. Gilliam seat on Caris Life Sciences, Inc., effective 2021-01-01.
  • Lloyd B. Minor seat on Caris Life Sciences, Inc., effective 2021-01-01.
  • Audit; Compensation committee of Caris Life Sciences, Inc., effective 2021-01-01.
  • Joseph E. Gilliam member of Audit; Compensation, effective 2021-01-01.
  • Brian J. Brille seat on Caris Life Sciences, Inc., effective 2018-01-01.
  • Danny Phillips seat on Caris Life Sciences, Inc., effective 2015-01-01.
  • Dominic Phillips seat on Caris Life Sciences, Inc., effective 2015-01-01.
  • Audit · Chair committee of Caris Life Sciences, Inc., effective 2015-01-01.
  • Dominic Phillips member of Audit · Chair, effective 2015-01-01.
  • Jon S. Halbert seat on Caris Life Sciences, Inc., effective 2014-01-01.
  • David Dean Halbert seat on Caris Life Sciences, Inc., effective 2008-01-01.
  • David Dean Halbert, D.Sc. (h.c.) seat on Caris Life Sciences, Inc., effective 2008-01-01.
  • Laura I. Johansen seat on Caris Life Sciences, Inc., effective 2008-01-01.
  • Peter M. Castleman seat on Caris Life Sciences, Inc., effective 2008-01-01.
  • Audit; Compensation · Chair committee of Caris Life Sciences, Inc., effective 2008-01-01.
  • Peter M. Castleman member of Audit; Compensation · Chair, effective 2008-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:8d0ee88f-5c33-4094-8769-1b6f153c3272, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/caris-life-sciences-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership16
  4. Board12
  5. Committees5
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims4
  15. Coverage gaps17
  16. Linked people27
  17. Subject and corrections6
  18. Evidence19
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:8d0ee88f-5c33-4094-8769-1b6f153c3272
  • Cite this recordCaris Life Sciences, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/caris-life-sciences-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Caris Life Sciences, Inc.Company
  • Brian J. BrillePerson
  • J. Russel DentonPerson
  • Michael HalbertPerson
  • Andreas S. TsukadaPerson
  • David Dean HalbertPerson
  • David SpetzlerPerson
  • George W. Sledge Jr.Person
  • Ginger AppleberryPerson
  • Jeremy O'BrienPerson
  • Jim AbrahamPerson
  • Jon Mark HarmonPerson
  • Luke PowerPerson
  • Matthew OberleyPerson
  • Milan RadovichPerson
  • Narendra ChokshiPerson
  • Valeriy DomenyukPerson
  • Danny PhillipsPerson
  • David Dean HalbertPerson
  • David Dean Halbert, D.Sc. (h.c.)Person
  • David FredricksonPerson
  • Dominic PhillipsPerson
  • Jeffrey VacircaPerson
  • Jon S. HalbertPerson
  • Joseph E. GilliamPerson
  • Laura I. JohansenPerson
  • Lloyd B. MinorPerson
  • Peter M. CastlemanPerson
  • Sections
    OverviewCaris Life Sciences, Inc.
  • MonitoringCaris Life Sciences, Inc.
  • LeadershipCaris Life Sciences, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.